Takeda Pharmaceutical (TAK) Receivables - Net: 2018-2025
- Takeda Pharmaceutical's Receivables - Net rose 4.20% to $5.1 billion in Q1 2025 from the same period last year, while for Mar 2025 it was $5.1 billion, marking a year-over-year increase of 4.20%. This contributed to the annual value of $5.1 billion for FY2025, which is 1.55% up from last year.
- According to the latest figures from Q1 2025, Takeda Pharmaceutical's Receivables - Net is $5.1 billion, which was up 4.20% from $4.8 billion recorded in Q1 2024.
- In the past 5 years, Takeda Pharmaceutical's Receivables - Net registered a high of $7.4 billion during Q1 2021, and its lowest value of -$80.8 million during Q1 2022.
- Its 3-year average for Receivables - Net is $3.3 billion, with a median of $4.8 billion in 2024.
- Its Receivables - Net has fluctuated over the past 5 years, first tumbled by 101.08% in 2022, then skyrocketed by 8,820.35% in 2024.
- Takeda Pharmaceutical's Receivables - Net (Quarterly) stood at $7.4 billion in 2021, then plummeted by 101.08% to -$80.8 million in 2022, then spiked by 31.17% to -$55.6 million in 2023, then skyrocketed by 8,820.35% to $4.8 billion in 2024, then rose by 4.20% to $5.1 billion in 2025.
- Its last three reported values are $5.1 billion in Q1 2025, $4.8 billion for Q1 2024, and -$55.6 million during Q1 2023.
